The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer
NCT ID: NCT03418207
Last Updated: 2018-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2018-02-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946
Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions
NCT06841211
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TTMB for patients
give trans-perineal template-guided mapping biopsy for participants suspected prostate cancer
trans-perineal template-guided mapping biopsy
new super saturation of prostate biopsy technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trans-perineal template-guided mapping biopsy
new super saturation of prostate biopsy technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2.18 yrs and older, and 90 yrs and younger;
3.Rectal examination reveal prostate nodules;
4.B ultrasound, CT or MRI find abnormal images;
5.PSA\>4ng/ml, abnormal f/t ratio and PSAD
Exclusion Criteria
2. Severe urinary tract infection;
3. Serious cardiovascular and cerebrovascular disease
18 Years
90 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Subei People's Hospital of Jiangsu Province
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xuefei Ding,MD
Chief physician of urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xuefei Ding, MD
Role: PRINCIPAL_INVESTIGATOR
Subei People's Hospital of Jiangsu Province
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Subei People's Hospital of Jiangsu province
Yangzhou, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tran M, Thompson J, Bohm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker PD. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy. BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090. Epub 2015 May 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SubeiPHJP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.